Donanemab showed significant slowing of decline in a composite measure of cognition and daily function in patients with early symptomatic Alzheimer's disease compared to placebo, as per phas..查看文章
Eli Lilly (NYSE:LLY) gains 20% in premarket on promising results from Phase 2 TRAILBLAZER-ALZ study, evaluating donanemab, an antibody that targets a modified form of beta amyloid
The amyloid theory continues to grasp at life as Eli Lilly has unveiled new phase 2 data from donanemab that show it can help Alzheimer’s disease patients by clearing these plaques out of th..查看文章
Eli Lilly today released topline Phase II data showing that its modified beta amyloid-targeting antibody donanemab significantly slowed decline in a composite measure of cognition and daily..查看文章
Donanemab, an investigational antibody that targets a modified form of beta amyloid called N3pG, showed significant slowing of decline in a composite measure of cognition and daily function..查看文章
Donanemab与发音含义,同义词,反义词,翻译,刑和更多的